Business Description
Medicus Pharma Ltd
NAICS : 325410
SIC : 3741
ISIN : CA58471K1030
Total Employee Number:
12Description
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.7 | |||||
Equity-to-Asset | -0.07 | |||||
Debt-to-Equity | -12.27 | |||||
Debt-to-EBITDA | -0.5 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -139.3 | |||||
3-Year EPS without NRI Growth Rate | -118.2 | |||||
3-Year FCF Growth Rate | -115.9 | |||||
3-Year Book Growth Rate | 87.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 45.57 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 12.28 | |||||
9-Day RSI | 19.94 | |||||
14-Day RSI | 26.7 | |||||
3-1 Month Momentum % | 0.5 | |||||
6-1 Month Momentum % | -36.15 | |||||
12-1 Month Momentum % | -84.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.57 | |||||
Cash Ratio | 1.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -46.2 | |||||
Shareholder Yield % | -314.7 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -12227.22 | |||||
ROA % | -336.94 | |||||
ROIC % | -596.09 | |||||
3-Year ROIIC % | 511.98 | |||||
ROC (Joel Greenblatt) % | -25538.28 | |||||
ROCE % | -1053.44 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.39 | |||||
EV-to-Forward-EBIT | -2.25 | |||||
EV-to-EBITDA | -0.39 | |||||
EV-to-Forward-EBITDA | -0.87 | |||||
EV-to-FCF | -0.57 | |||||
Earnings Yield (Greenblatt) % | -256.41 | |||||
FCF Yield % | -285.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MDCX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicus Pharma Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.47 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 109.88 | ||
| 14-Day RSI | 26.7 | ||
| 14-Day ATR ($) | 0.028289 | ||
| 20-Day SMA ($) | 0.244909 | ||
| 12-1 Month Momentum % | -84.16 | ||
| 52-Week Range ($) | 0.1512 - 3.05 | ||
| Shares Outstanding (Mil) | 63.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicus Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicus Pharma Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 63 days | ||
| Second quarter earnings results for 2026 | 2026-08-18 | 0.26 (-7.51%) | ||
| General meeting for 2026 | 2026-06-03 10:00 | 0.33 (-2.68%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 0.32 (+2.69%) | ||
| Medicus Pharma Business Update Conference Call | 2026-03-26 11:30 | 0.49 (+2.90%) | ||
| Annual report for 2025 | 2026-03-25 | 0.49 (-0.12%) | ||
| 38(th) Annual Roth Conference | 2026-03-24 12:30 | 0.50 (-1.77%) | ||
| Guidance call for 2026 | 2026-01-13 10:00 | 1.46 (-5.81%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 2.26 (-5.44%) | ||
| Second quarter earnings results for 2025 | 2025-08-11 | 1.97 (-10.45%) |
Show
Entries
Medicus Pharma Ltd Frequently Asked Questions
What is Medicus Pharma Ltd(MDCX)'s stock price today?
The current price of MDCX is $0.16. The 52 week high of MDCX is $3.05 and 52 week low is $0.15.
When is next earnings date of Medicus Pharma Ltd(MDCX)?
The next earnings date of Medicus Pharma Ltd(MDCX) is 2026-11-13 Est..
Does Medicus Pharma Ltd(MDCX) pay dividends? If so, how much?
Medicus Pharma Ltd(MDCX) does not pay dividend.
Press Release
Headlines
See More- 1
Sep 03, 2026
Pfizer, Medicus ink licensing deal worth up to $1B for antibody drug conjugate
Seeking Alpha • 9:52am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers